Envoy Medical, Inc. COCH
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2021-03-02
Chart by TradingView
2/9
Piotroski F — financial health
-141.55
Altman Z″ — distress risk · distress
-7.7%
Dividend payout · safe
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $241,000 | $225,000 | $316,000 | $237,000 | — |
| Operating income | -$22.3M | -$19.3M | -$18.4M | -$8.7M | -$5.2M |
| Net income | -$23.8M | -$20.8M | -$29.9M | -$15.9M | -$251,633 |
| Operating cash flow | -$18.2M | -$17.9M | -$17.1M | -$8.8M | -$3.2M |
| Free cash flow | -$18.4M | -$18.9M | -$17.2M | -$9.0M | — |
| Total assets | $8.6M | $11.5M | $8.3M | $2.6M | $426.9M |
| Total liabilities | $20.3M | $30.4M | $10.0M | $38.8M | $38.6M |
| Shareholders' equity | -$12.2M | -$18.8M | -$1.8M | -$36.2M | -$45.0M |
| Ratios | |||||
| Operating margin | -9240.7% | -8558.2% | -5809.8% | -3673.4% | — |
| Net margin | -9857.3% | -9242.2% | -9469.0% | -6718.6% | — |
| FCF margin | -7626.6% | -8412.9% | -5457.0% | -3807.2% | — |
| Return on assets | -277.6% | -180.2% | -361.8% | -623.0% | -0.1% |
| Return on equity | 195.4% | 110.4% | 1684.8% | 44.0% | 0.6% |
| Current ratio | 0.54 | 1.18 | 1.02 | 0.65 | 0.32 |
| Revenue growth | 7.1% | -28.8% | 33.3% | — | — |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -141.55 (distress)
- Working capital / assets -0.617
- Retained earnings / assets -36.62
- EBIT / assets -2.602
- Equity / liabilities -0.598
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001840877 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.